Our Portfolio


filter by

Program

Research Area

Cancer Types

Current/Former recipients

A Model System for Robust Identification of Neoantigen-Specific T-cell Receptors

ASPIRE AWARD (2018-2020; 2020-PRESENT)

Michelle Krogsgaard, PhD (Principal); Jef Boeke, PhD; and Jeffrey Weber, MD, PhD, New York University

Read More

Tumor-Specific Immunotherapy for a Rare Pediatric Liver Cancer

ASPIRE Award (2020-Present)

Paul Thomas, PhD, St. Jude Children’s Research Hospital

Read More

Convergence of Machine Learning and Translational Genomics for Prostate Cancer Precision Medicine

2020 Emerging Leader Award - Arnold J. Levine Fellow

Eliezer Van Allen, MD, Dana-Farber Cancer Institute

Read More

Drug Combinations to Preempt Resistance in AML

2020 Emerging Leader Award

Jeffrey Tyner, PhD, Oregon Health and Science University

Read More

Targeting Cellular States and Plasticity in Glioblastoma

2020 Emerging Leader Award

Mario Suvà, MD, PhD, Massachusetts General Hospital

Read More

Exploiting Lymphatic Transport for Early Detection

2020 Emerging Leader Award

Amanda Lund, PhD, New York University

Read More

Mechanism of cGAS-STING Inactivation in Antitumor Immunity and Disease

2020 Emerging Leader Award

Philip Kranzusch, PhD, Dana-Farber Cancer Institute

Read More

Improving Cancer Immunotherapy through Metabolic Modulation

2020 Emerging Leader Award

Greg Delgoffe, PhD, The University of Pittsburgh

Read More

Long-Range Tumor-Host Signaling Mechanisms Driving Paraneoplastic Syndromes

Damon Runyon - Mark Foundation Postdoctoral Fellow (2020-Present)

Katy Ong, PhD, University of California, Berkeley

Read More

Generating a Long-term Immune Response to Merkel Cell Carcinoma

ASPIRE Award (2020-Present)

Paul Nghiem, MD, PhD, University of Washington

Read More

Load More